{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:13:15Z","timestamp":1784905995291,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09903-0","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:47:50Z","timestamp":1784904470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) trial\u2014rationale for the selected lower steroid dose"],"prefix":"10.1186","volume":"27","author":[{"name":"The WHO ACTION Trials Collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebunoluwa Aderonke","family":"Adejuyigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubukola Adeponle","family":"Adesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabina","family":"Ariff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adejumoke Idowu","family":"Ayede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Baqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Chellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha Begum","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"De Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangappa M.","family":"Dhaded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprasad S.","family":"Goudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwafemi","family":"Kuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Minckas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Huong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufemi T.","family":"Oladapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshita V.","family":"Pujar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahida P.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman P. N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammod","family":"Shahidullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumaan","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajid","family":"Soofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Were","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"4","key":"9903_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1677\/joe.0.0450515","volume":"45","author":"GC Liggins","year":"1969","unstructured":"Liggins GC. Premature delivery of fetal lambs infused with glucocorticoids. J Endocrinol. 1969;45(4):515\u201323.","journal-title":"J Endocrinol"},{"key":"9903_CR2","doi-asserted-by":"publisher","unstructured":"Liggins GC, Howie RN. Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50(4):515\u201325. Available from: https:\/\/doi.org\/10.1542\/peds.50.4.515","DOI":"10.1542\/peds.50.4.515"},{"key":"9903_CR3","doi-asserted-by":"publisher","unstructured":"McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2020;12(2):CD004454. Available from: https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4","DOI":"10.1002\/14651858.CD004454.pub4"},{"key":"9903_CR4","doi-asserted-by":"publisher","unstructured":"Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2013;(8):CD006764. Available from: https:\/\/doi.org\/10.1002\/14651858.CD006764.pub3","DOI":"10.1002\/14651858.CD006764.pub3"},{"key":"9903_CR5","doi-asserted-by":"publisher","unstructured":"Kemp MW, Schmidt AF, Jobe AH. Optimizing antenatal corticosteroid therapy. Semin Fetal Neonatal Med 2019;24(3):176\u201381. Available from: https:\/\/doi.org\/10.1016\/j.siny.2019.05.003","DOI":"10.1016\/j.siny.2019.05.003"},{"key":"9903_CR6","doi-asserted-by":"publisher","unstructured":"Crowther CA, Ashwood P, Andersen CC, Middleton PF, Tran T, Doyle LW, et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health 2019;3(11):769\u201380. Available from: https:\/\/doi.org\/10.1016\/S2352-4642(19)30292-5","DOI":"10.1016\/S2352-4642(19)30292-5"},{"key":"9903_CR7","volume-title":"Recommendations on antenatal corticosteroids for improving preterm birth outcomes","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Recommendations on antenatal corticosteroids for improving preterm birth outcomes. Geneva: World Health Organization; 2022."},{"issue":"5","key":"9903_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2265.1991.tb03564.x","volume":"35","author":"A Donaldson","year":"1991","unstructured":"Donaldson A, Nicolini U, Symes EK, Rodeck CH, Tannirandorn Y, Tannirandorn Y. Changes in concentrations of cortisol, dehydroepiandrosterone sulphate and progesterone in fetal and maternal serum during pregnancy. Clin Endocrinol (Oxf). 1991;35(5):447\u201351.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9903_CR9","doi-asserted-by":"publisher","unstructured":"Schmitz T, Alberti C, Ursino M, Baud O, Aupiais C, BETADOSE study group and the GROG (Groupe de Recherche en Gyn\u00e9cologie Obst\u00e9trique). Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE). BMC Pregnancy Childbirth 2019;19(1):67. Available from: https:\/\/doi.org\/10.1186\/s12884-019-2206-x","DOI":"10.1186\/s12884-019-2206-x"},{"key":"9903_CR10","doi-asserted-by":"publisher","unstructured":"R\u00e4ikk\u00f6nen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA 2020;323(19):1924\u201333. Available from: https:\/\/doi.org\/10.1001\/jama.2020.3937","DOI":"10.1001\/jama.2020.3937"},{"key":"9903_CR11","doi-asserted-by":"publisher","unstructured":"Lin Y-H, Lin C-H, Lin M-C, Hsu Y-C, Hsu C-T. Antenatal corticosteroid exposure is associated with childhood mental disorders in late preterm and term infants. J Pediatr 2023;253:245\u2013251.e2. Available from: https:\/\/doi.org\/10.1016\/j.jpeds.2022.09.050","DOI":"10.1016\/j.jpeds.2022.09.050"},{"key":"9903_CR12","doi-asserted-by":"publisher","unstructured":"Wolford E, Lahti-Pulkkinen M, Girchenko P, Lipsanen J, Tuovinen S, Lahti J, et al. Associations of antenatal glucocorticoid exposure with mental health in children. Psychol Med 2020;50(2):247\u201357. Available from: https:\/\/doi.org\/10.1017\/S0033291718004129","DOI":"10.1017\/S0033291718004129"},{"issue":"1","key":"9903_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13063-024-07941-0","volume":"25","author":"WHO ACTION Trial collaborators","year":"2024","unstructured":"WHO ACTION Trial collaborators. The World Health Organization antenatal corticosteroids for improving outcomes in preterm newborns (ACTION-III) trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries. Trials. 2024;25(1):258.","journal-title":"Trials"},{"key":"9903_CR14","doi-asserted-by":"publisher","unstructured":"Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56(6):1548\u201354. Available from: https:\/\/doi.org\/10.1172\/JCI108236","DOI":"10.1172\/JCI108236"},{"key":"9903_CR15","doi-asserted-by":"publisher","unstructured":"Kemp MW, Saito M, Usuda H, Watanabe S, Sato S, Hanita T, et al. The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy. Am J Obstet Gynecol 2018;219(3):301.e1\u2013301.e16. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2018.05.007","DOI":"10.1016\/j.ajog.2018.05.007"},{"key":"9903_CR16","doi-asserted-by":"publisher","unstructured":"Schmidt AF, Kemp MW, Rittenschober-B\u00f6hm J, Kannan PS, Usuda H, Saito M, et al. Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep. Am J Obstet Gynecol 2018;218(1):132.e1\u2013132.e9. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2017.11.560","DOI":"10.1016\/j.ajog.2017.11.560"},{"key":"9903_CR17","doi-asserted-by":"publisher","unstructured":"Schmidt AF, Kannan PS, Bridges JP, Filuta A, Lipps D, Kemp M, et al. Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques. Sci Rep 2019;9(1):9039. Available from: https:\/\/doi.org\/10.1038\/s41598-019-45171-6","DOI":"10.1038\/s41598-019-45171-6"},{"key":"9903_CR18","doi-asserted-by":"publisher","unstructured":"Gyamfi C, Mele L, Wapner RJ, Spong CY, Peaceman A, Sorokin Y, et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol 2010;203(3):219.e1\u20135. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2010.04.047","DOI":"10.1016\/j.ajog.2010.04.047"},{"key":"9903_CR19","doi-asserted-by":"publisher","unstructured":"Foissac F, Zheng Y, Hirt D, Lui G, Bouazza N, Ville Y, et al. Maternal betamethasone for prevention of respiratory distress syndrome in neonates: Population pharmacokinetic and pharmacodynamic approach. Clin Pharmacol Ther 2020;108(5):1026\u201335. Available from: https:\/\/doi.org\/10.1002\/cpt.1887","DOI":"10.1002\/cpt.1887"},{"key":"9903_CR20","unstructured":"Betamethasone and Severity of Hyaline Membrane Disease (b-Mhyalines). ClinicalTrials.gov Identifier: NCT01854840. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01854840"},{"key":"9903_CR21","doi-asserted-by":"publisher","unstructured":"Ballabh P, Lo ES, Kumari J, Cooper TB, Zervoudakis I, Auld PAM, et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002;71(1):39\u201345. Available from: https:\/\/doi.org\/10.1067\/mcp.2002.120250","DOI":"10.1067\/mcp.2002.120250"},{"key":"9903_CR22","doi-asserted-by":"publisher","unstructured":"Jobe AH, Milad MA, Peppard T, Jusko WJ. Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India. Clin Transl Sci 2020;13(2):391\u20139. Available from: https:\/\/doi.org\/10.1111\/cts.12724","DOI":"10.1111\/cts.12724"},{"key":"9903_CR23","doi-asserted-by":"publisher","unstructured":"Krzyzanski W, Milad MA, Jobe AH, Jusko WJ. Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: Application to antenatal corticosteroids. CPT Pharmacometrics Syst Pharmacol 2023;12(5):668\u201380. Available from: https:\/\/doi.org\/10.1002\/psp4.12899","DOI":"10.1002\/psp4.12899"},{"key":"9903_CR24","doi-asserted-by":"publisher","unstructured":"Ke AB, Milad MA. Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using physiologically-based pharmacokinetic modeling. Clin Pharmacol Ther 2019;106(1):164\u201373. Available from: https:\/\/doi.org\/10.1002\/cpt.1438.","DOI":"10.1002\/cpt.1438"},{"key":"9903_CR25","doi-asserted-by":"publisher","unstructured":"Anoshchenko O, Milad MA, Unadkat JD. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. CPT Pharmacometrics Syst Pharmacol 2021;10(9):1057\u201370. Available from: https:\/\/doi.org\/10.1002\/psp4.12674","DOI":"10.1002\/psp4.12674"},{"key":"9903_CR26","doi-asserted-by":"publisher","unstructured":"Van Der Heijden JEM, Van Hove H, Van Elst NM, Van Den Broek P, Van Drongelen J, Scheepers HCJ, et al. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach. Am J Obstet Gynecol 2025;232(2):228.e1\u2013228.e9. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2024.05.012","DOI":"10.1016\/j.ajog.2024.05.012"},{"key":"9903_CR27","doi-asserted-by":"publisher","unstructured":"Jobe AH, Kemp M, Schmidt A, Takahashi T, Newnham J, Milad M. Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatr Res 2021;89(2):318\u201325. Available from: https:\/\/doi.org\/10.1038\/s41390-020-01249-w","DOI":"10.1038\/s41390-020-01249-w"},{"key":"9903_CR28","doi-asserted-by":"publisher","unstructured":"Takahashi T, Fee EL, Takahashi Y, Saito M, Yaegashi N, Usuda H, et al. Betamethasone phosphate reduces the efficacy of antenatal steroid therapy and is associated with lower birthweights when administered to pregnant sheep in combination with betamethasone acetate. Am J Obstet Gynecol 2022;226(4):564.e1\u2013564.e14. Available from: https:\/\/doi.org\/10.1016\/j.ajog.2021.10.001","DOI":"10.1016\/j.ajog.2021.10.001"},{"key":"9903_CR29","doi-asserted-by":"publisher","unstructured":"Schmitz T, Doret-Dion M, Sentilhes L, Parant O, Claris O, Renesme L, et al. Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. Lancet 2022;400(10352):592\u2013604. Available from: https:\/\/doi.org\/10.1016\/S0140-6736(22)01535-5","DOI":"10.1016\/S0140-6736(22)01535-5"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09903-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09903-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:47:51Z","timestamp":1784904471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09903-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9903"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09903-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate\n                      This is a commentary with no human participant involvement; therefore, ethics approval was not required. Ethics approval for the WHO ACTION-III trial is detailed in the trial protocol [\n                      \n                      ].","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The members of the WHO ACTION Trials Collaborators consent to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"510"}}